Apteka Exhibition Russian Health Care Week UFI Approved Event
To main
For exhibitors
For visitors
Program
Contacts

Trevena Appoints Roberto Cuca as Senior Vice President & Chief Financial Officer

18.09.2013

KING OF PRUSSIA, Pa., Sept. 17, 2013 /PRNewswire/ — Trevena, Inc., (Trevena) a clinical stage pharmaceutical company and a leader in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced the appointment of Roberto Cuca as senior vice president and chief financial officer.

«We are delighted to have Roberto join Trevena at this pivotal juncture in the company’s development," said Maxine Gowen, Ph. D., president and chief executive officer of Trevena. «Roberto’s diverse experience in effectively transitioning both private and public healthcare companies through phases of rapid growth will be invaluable in assisting Trevena through its corporate and strategic evolution.»

Mr. Cuca brings to Trevena nearly 20 years of experience in the pharmaceutical and biotechnology industries. Most recently, he served as Treasurer and Senior Vice President, Finance at Endo Health Solutions Inc., a specialty healthcare company. Before that, he was Director, Corporate and Business Development, at moksha8 Pharmaceuticals, Inc., a pharmaceutical company focused on emerging markets. Mr. Cuca also worked at JPMorgan Chase & Co. as an equity analyst covering U.S. pharmaceutical companies. He received an M.B.A. from the Wharton School of The University of Pennsylvania, a J.D. from Cornell Law School, an A.B. from Princeton University and he is a CFA charterholder.

«I am excited to join Trevena and work with its exceptional team at a time of such great promise," said Mr. Cuca. «The company has made significant progress in advancing its compounds into the clinic, collaborating with world-class global pharmaceutical companies and successfully securing financing to support the development of its clinical programs. I look forward to helping the company progress towards its next phase of development.»

Source: firstwordpharma.com


Back to the list

exhibitor's opinion
Photo gallary

Invite partners to the exhibition
Facebook Youtube RSS Feed





Contacts Flashback Site map
119002 Moscow, Arbat str., 35, of. 423
Тel: +7 (495) 925-65-61/62
Fax: +7 (499) 248-07-34